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OBJECTIVE — The purpose of this study was to assess the association between exercise
capacity and mortality in African Americans and Caucasians with type 2 diabetes and to explore
racial differences regarding this relationship.
RESEARCH DESIGN AND METHODS — African American (n  1,703; aged 60  10
years) and Caucasian (n  1,445; aged 62  10 years) men with type 2 diabetes completed a
maximal exercise test between 1986 and 2007 at the Veterans Affairs Medical Centers in Wash-
ington,DC,andPaloAlto,California.Threeﬁtnesscategorieswereestablished(low-,moderate-,
and high-ﬁt) based on peak METs achieved. Subjects were followed for all-cause mortality for
7.3  4.7 years.
RESULTS — The adjusted mortality risk was 23% higher in African Americans than in Cau-
casians (hazard ratio 1.23 [95% CI 1.1–1.4]). A graded reduction in mortality risk was noted
with increased exercise capacity for both races. There was a signiﬁcant interaction between race
and METs (P  0.001) and among race and ﬁtness categories (P  0.001). The association was
stronger for Caucasians. Each 1-MET increase in exercise capacity yielded a 19% lower risk for
Caucasiansand14%forAfricanAmericans(P0.001).Similarly,theriskwas43%lower(0.57
[0.44–0.73]) for moderate-ﬁt and 67% lower (0.33 [0.22–0.48]) for high-ﬁt Caucasians. The
comparable reductions in African Americans were 34% (0.66 [0.55–0.80]) and 46% (0.54
[0.39–0.73]), respectively.
CONCLUSIONS — Exercise capacity is a strong predictor of all-cause mortality in African
American and Caucasian men with type 2 diabetes. The exercise capacity-related reduction in
mortality appears to be stronger and more graded for Caucasians than for African Americans.
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P
oor exercise capacity is a well-
established independent predictor
of cardiovascular and overall mor-
talityamonghealthysubjectsandpatients
with diabetes and/or cardiovascular dis-
ease (CVD) (1–5), whereas increased
physical activity and higher cardiorespi-
ratory ﬁtness confer health beneﬁts in
proportion to the level of ﬁtness (1,2,6),
independent of BMI (3,4). Increases in
physical activity patterns have thus
emerged as an integral part of the preven-
tion and management of type 2 diabetes
(5–7).
African Americans have a two- to six-
fold higher risk for developing diabetes
(8) and approximately double the diabe-
tes death rate (9) compared with Cauca-
sians. Socioeconomic and quality of
health care differences have been cited as
possible reasons for this apparent racial
disparity (10–12). When access to health
care is comparable, signiﬁcantly lower
overall mortality rates were reported
among a National population of African
American veterans versus Caucasians
with diabetes (10).
An intriguing ﬁnding is that African
American diabetic subjects exhibit signif-
icantly lower exercise capacity than do
Caucasian diabetic subjects (13). The re-
lationship between exercise capacity and
mortality risk in African American dia-
betic subjects has not been reported pre-
viously, and possible racial differences
regarding this relationship have not been
explored.
The Veterans Health Administration
intheU.S.DepartmentofVeteransAffairs
Health Care System ensures equal access
to high-quality health care independent
of a patient’s ﬁnancial status (14). In ad-
dition, the Veterans Affairs Medical Cen-
ter (VAMC) electronic health information
database is well suited to determine mor-
tality accurately (15), thus providing an
opportunity to assess the association be-
tween exercise capacity and mortality un-
der comparable medical care.
In the present study, we assessed the
relationship between exercise capacity
and all-cause mortality in diabetic sub-
jects and possible racial differences re-
garding this relationship.
RESEARCH DESIGN AND
METHODS— Between July 1986 and
30 November 2007, a symptom-limited
exercise tolerance test (ETT) was admin-
istered to veterans with type 2 diabetes at
the VAMC in Washington, DC, and Palo
Alto, California, either as part of routine
evaluations or to assess exercise-induced
ischemia.Thisinformationalongwiththe
individual’s medical history has been
electronically stored.
From this database we excluded
womenandthosewithanyofthefollowing:
1) history of an implanted pacemaker, 2)
left bundle branch block, 3) unstable
symptom,and4)impairedchronotropicre-
sponse. After these exclusions, the partici-
pant group comprised 1,703 African
Americans and 1,445 Caucasians. The
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view board at each institution, and all sub-
jects gave written informed consent before
undergoing ETT.
All demographic, clinical, and medi-
cation information was obtained from the
individual’s computerized medical
records just before ETT. Each individual
was asked to verify the computerized in-
formation, including history of chronic
disease, current medications, and smok-
ing habits. Body weight and height were
assessed by a standardized scale and re-
cordedbeforethetest.BMIwascalculated
as weight in kilograms divided by the
square of height in meters. Demographic
data are included in Table 1.
Dates of death were veriﬁed from the
Veterans Affairs Beneﬁciary Identiﬁcation
and Record Locator System File. This sys-
tem is used to determine beneﬁts to sur-
vivors of veterans, and it has been shown
to be complete and accurate (95%) (16).
Vital status was determined as of 28 Feb-
ruary 2008.
Exercise testing was performed using
the Bruce protocol at the VAMC in Wash-
ington, DC, and by an individualized
ramp protocol as described elsewhere
(17) at the VAMC in Palo Alto, California.
Peak exercise capacity (METs) was esti-
mated using standardized equations
based on peak speed and grade for the
ramp protocol (17) and on peak exercise
time for the Bruce protocol (18). Subjects
were encouraged to exercise until voli-
tional fatigue in the absence of symptoms
or other indications for stopping (19).
The use of handrails was discouraged but
allowed when necessary for balance and
safety. Age-predicted peak exercise heart
ratewasdeterminedonthebasisofapop-
ulation-speciﬁc equation (20). Medica-
tions were not altered before testing.
Three ﬁtness categories were estab-
lished on the basis of the MET level
achieved. Those who achieved a peak
MET level 5 METs (lowest 25%) of the
METs achieved by the cohort comprised
the low ﬁtness category (low-ﬁt; n 
934); those whose MET level was 75%
(8 METs) comprised the highest ﬁtness
category (high-ﬁt; n  762). Those re-
maining (5.1–7.9 MET level) comprised
the moderate ﬁtness category (moderate-
ﬁt; n  1,452).
Statistical analysis
Follow-up time is presented as mean 
SD and median of years. Mortality rate
wascalculatedastheratioofeventsbythe
numberofpersonsorbytheperson-years
of observation. Continuous variables are
presented as mean values  SD and cate-
gorical variables as relative frequencies
(percentage). Associations between cate-
gorical variables were tested using 
2
analysis. One-way ANOVA was applied
to determine age and BMI differences
between races and ﬁtness categories.
Because of racial differences in age,
ANCOVAwasusedtoassesswhetherracial
difference existed in exercise test vari-
ables, using age as a covariate. Age and
BMI were used as covariates when com-
parisons among ﬁtness categories were
made. Post hoc procedures were per-
formed(Bonferroni)formultiplecompar-
isons. Equality of variances between
groups was tested by Levene’s test.
Therelativeriskformortalitywascal-
culated for each ﬁtness category. Kaplan-
Meier survival curves were generated for
the three ﬁtness categories. Cox propor-
tional hazard models were used to deter-
mine the variables that were signiﬁcantly
associated with mortality among ﬁtness
categories.Theanalyseswereadjustedfor
age, BMI, history of CVD, cardiovascular
medications (ACE inhibitors, -blockers,
calcium channel blocker, diuretics, and
statins) and risk factors (hypertension,
dyslipidemia, and smoking). Racial dif-
ferences regarding the effect of exercise
capacity on mortality risk were tested us-
ing a dummy variable that combined the
exercise data with race. P  0.05 using
two-sided tests was considered statisti-
cally signiﬁcant. All statistical analyses
wereperformedusingSPSSsoftware(ver-
sion 15.0; SPSS, Chicago, IL).
RESULTS— The mean  SD fol-
low-up period was 7.3  5 years (median
6.4)and23,137person-years.Therewere
823 deaths (26.1%), resulting in an aver-
age annual mortality of 3.56%. Of those
Table 1—Demographic and clinical characteristics for African Americans and Caucasians
with type 2 diabetes
Total
African
American Caucasian P*
n 3,148 1,703 1,445 —
Age (years) 61  10 60  10 62  10 0.001
BMI (kg/m
2) 30  5.6 30  5.5 30  5.7 0.27
Resting heart rate (beats/min) 76  14 76  14 76  14 0.82
Resting systolic blood
pressure (mmHg) 135  21 136  22 134  21 0.1
Resting diastolic blood
pressure (mmHg) 80  12 81  12 78  12 0.001
CVD (%) 49.7 51.7 47.3 0.001
Smoking (%) 42 35.1 50.2 0.001
Hypertension (%) 73.6 75.6 71.3 0.007
Family history of coronary
heart disease 14.8 12.3 18.8 0.001
Dyslipidemia (%) 26.9 34.6 17.9 0.001
-Blockers (%) 18.3 13.1 24.4 0.001
Calcium channel blockers (%) 21.4 20.6 22.4 0.23
ACE inhibitors (%) 37.5 34.6 40.9 0.001
Diuretics (%) 15.7 18.6 12.3 0.001
Aspirin (%) 5.9 5.9 5.8 0.511
Statins (%) 14.6 9.4 20.7 0.001
Insulin (%) 30.7 33.7 22.8 0.001
Oral glycemic agents (%) 34.2 33.2 36.8 0.13
Exercise data*
Peak heart rate (beats/min) 135  25 138  25 131  25 0.001
Peak systolic blood
pressure (mmHg) 183  32 188  33 176  31 0.001
Peak diastolic blood
pressure (mmHg) 86  16 89  16 82  15 0.001
Peak METs (3.5 ml O2  
kg
1   min
1) 6.4  2.3 6.3  2.0 6.5  2.6 0.001
Data are means  SD. *P values represent comparisons between African Americans and Caucasians.
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icans and 314 (21.7%) were Caucasians.
Approximately 79% of subjects
achievedapeakheartrateof85%ofthe
age-predicted value. Approximately 44%
of those who did not achieve this level
were receiving -blockers.
Participants’ characteristics and exer-
cise data are presented in Table 1. African
AmericanswereyoungerthanCaucasians
(P  0.001). After controlling for age, Af-
rican Americans had higher resting dia-
stolic blood pressure and were more
likely to have CVD, hypertension, and
dyslipidemia and to be treated with di-
ureticsandinsulin.Caucasiansweremore
likely to smoke, have a family history of
coronary heart disease, and be treated
with -blockers, ACE inhibitors, statins,
and oral glycemic agents. After adjust-
ment for age and resting diastolic blood
pressure, the peak exercise systolic and
diastolic blood pressure and heart rate
weresigniﬁcantlyhigherinAfricanAmer-
icans versus Caucasians, whereas peak
MET level was higher in Caucasians.
Adjusted mortality for age, CVD, risk
factors, resting diastolic blood pressure,
cardiovascular medication, insulin and
oral glycemic agents, and METs revealed
that all-cause mortality was 23% higher
(hazard ratio [HR] 1.23 [95% CI [1.02–
1.47]; P  0.02) in African Americans
than in Caucasians. This relationship was
consistent within moderate-ﬁt (1.31
[1.04–1.64]) and high-ﬁt categories
(2.31[1.44–3.70])withnosigniﬁcantra-
cial differences in mortality rates within
the low-ﬁt category (1.16 [0.94–1.44]).
AfricanAmericanswhodiedweresig-
niﬁcantlyolder(6410vs.599years;
P0.001)andhadhigherrestingsystolic
blood pressure (143  23 vs. 133  21
mmHg; P  0.001) compared with those
still alive. They also had lower BMI
(28.7  5.4 vs. 30.7  5.5; P  0.001)
andweremorelikelytosmokeandhavea
higher prevalence of CVD.
Similarly, Caucasians who died were
older(669vs.619years;P0.001)
and had higher resting systolic blood
pressure (139  23 vs. 133  20 mmHg;
P  0.001) than those alive. In addition,
they had signiﬁcantly lower BMI (28.4 
4.8 vs. 30.9  5.8; P  0.001) and dia-
stolic blood pressure (77  12 vs. 79 
11 mmHg; P  0.001) and were more
likely to have CVD.
Comparisons among ﬁtness catego-
ries revealed that age was signiﬁcantly
lower (P  0.001) for the high-ﬁt versus
moderate-ﬁt and low-ﬁt categories (56 
9.2, 61  10, and 65  9 years, respec-
tively).Similarﬁndingswereobservedfor
both races. BMI was lower (P  0.05) in
the high-ﬁt compared with the moderate-
ﬁt and low-ﬁt categories (30.3  5.9 vs.
30.6  5.6 vs. 29.5  5.1 for low-, mod-
erate-, and high-ﬁt, respectively). Thus,
age and BMI were used as covariates
when differences in resting and exercise
heart rate, blood pressure, and MET
levels among the ﬁtness categories were
assessed.
Exercise capacity and other clinical
predictors of total mortality for the entire
group and for each race are presented in
Table 2. Survival analysis revealed a 16%
reduction in mortality risk for every
1-METincreaseinexercisecapacityinthe
entirecohort(P0.001),14%inAfrican
Americans (P  0.001), and 19% in Cau-
casians (P  0.001).
Therewere394(42.2%)deathsinthe
low-ﬁt, 339 (23.3%) in the moderate-ﬁt,
and 90 (11.8%) in the high-ﬁt category
(Fig. 1). Among African Americans, there
were 230 (46.4%) deaths in the low-ﬁt,
224 (26.7%) in the moderate-ﬁt, and 55
(14.9%) in the high-ﬁt category. In Cau-
casians,therewere164(37.4%)deathsin
the low-ﬁt category, 115 (18.8%) in the
moderate-ﬁt, and 35 (8.9%) in the high-
ﬁt category.
To assess total mortality risk associ-
ated with exercise capacity, we compared
themoderate-andhigh-ﬁtcategorieswith
thelow-ﬁt(Coxproportionalhazard)cat-
egory. The adjusted relative risks of these
comparisons are presented in Table 3.
The risk of mortality was 37% lower for
those with an exercise capacity between
5.1 and 7.9 METs (P  0.001) and 67%
lower for those who achieved 8 METs
(P  0.001). The ﬁndings did not change
substantially when participants who died
within the ﬁrst year of follow-up were
excluded.
To assess racial differences in mortal-
ity risk, we probed for interaction be-
tween race and ﬁtness. A signiﬁcant
interaction was noted between race and
METs (P  0.001) and among race and
ﬁtness categories (P  0.001). Thus, we
examined mortality rates among ﬁtness
categories for each race (Table 3). The
low-ﬁt category was used as the referent.
InAfricanAmericans,therelativerisk
was 34% lower for those achieving 5.1–
7.9 METs (P  0.001) and 46% lower for
thoseachieving8METs(P0.001).In
Caucasians, the relative risk was 43%
lower (P  0.001) for those achieving
5.1–7.9 METs and 67% lower (P 
0.001) for those achieving 8 METs.
Finally, we addressed the effects of
exercise capacity on mortality risk when
expressed as a percentage of age-
predicted values, calculated on the basis
ofanequationderivedfromalargecohort
of veterans referred for exercise testing
(2). These analyses resulted in no signiﬁ-
cant differences relative to the ﬁndings
when exercise capacity was expressed as
an absolute value.
CONCLUSIONS — The ﬁndings of
thecurrentstudysupportastronginverse
and graded association between exercise
capacityandriskforall-causemortalityin
Table 2—HRs (95% CI) for all-cause mortality according to exercise capacity
HR (95% CI) P
All (n  3,148)
Peak exercise capacity (for each 1-MET increment) 0.79 (0.76–0.82) 0.001
Adjusted for age and BMI 0.82 (0.79–0.86) 0.001
Adjusted for age, BMI, cardiovascular risk factors,
CVD, and cardiovascular medications 0.84 (0.81–0.87) 0.001
African Americans (n  1,703)
Peak exercise capacity (for each 1-MET increment) 0.80 (0.76–0.84) 0.001
Adjusted for age and BMI 0.85 (0.93–0.96) 0.001
Adjusted age, BMI, cardiovascular risk factors,
CVD, and cardiovascular medications† 0.86 (0.82–0.90) 0.001
Caucasians (n  1,445)
Peak exercise capacity (for each 1-MET increment) 0.77 (0.73–0.82) 0.001
Adjusted for age and BMI 0.81 (0.76–0.85) 0.001
Adjusted age, BMI, cardiovascular risk factors,
CVD, and cardiovascular medications† 0.81 (0.77–0.86) 0.001
*Cardiovascularriskfactorsincludehypertension,dyslipidemia,andsmoking.†Cardiovascularmedications
include ACE inhibitors, -blockers, calcium channel blockers, diuretics, insulin, aspirin, and statins.
Kokkinos and Associates
DIABETES CARE, VOLUME 32, NUMBER 4, APRIL 2009 625middle-aged and older African American
and Caucasian male Veterans with type 2
diabetes. After adjustment for age, BMI,
cardiovascular risk factors, and cardiac
medications, total mortality risk was pro-
gressively lower as exercise capacity in-
creased beyond 5 METs (Table 3). Our
ﬁndings support previous reports of an
inverse relationship between aerobic ﬁt-
ness and total mortality in both healthy
and diseased populations (1–5). They
alsoconﬁrmapreviousreportinpredom-
inantly male Caucasian diabetic subjects
that the largest proportional reduction in
risk occurs between the least ﬁt and the
moderate ﬁt categories (4).
Thecurrentstudyisuniquebecauseit
is the ﬁrst to provide information on the
associationbetweenexercisecapacityand
mortality risk in African American men
withtype2diabetesandtocomparethese
Figure 1—Cumulative survival for the entire cohort according to ﬁtness categories.
Table 3—Relative risk for all-cause mortality according to ﬁtness categories
Low ﬁt Moderate ﬁt High ﬁt P*
MET level achieved 5 METs 5.1–7.9 METs 8 METs
Entire cohort (n  3,148)
Age-adjusted Referent 0.62 (0.53–0.71) 0.41 (0.32–0.52) 0.001
Multi-adjusted† Referent 0.63 (0.55–0.73) 0.41 (0.33–0.53) 0.001
Excluding deaths that occurred during
the ﬁrst year of follow-up Referent 0.63 (0.53–0.73) 0.43 (0.14–0.55) 0.001
African-Americans (n  1,703)
Age-adjusted Referent 0.65 (0.54–0.78) 0.54 (0.39–0.73) 0.001
Multi-adjusted† Referent 0.66 (0.55–0.80) 0.54 (0.39–0.73) 0.001
Excluding deaths that occurred during
the ﬁrst year of follow-up Referent 0.65 (0.53–0.79) 0.56 (0.40–0.77) 0.001
Caucasians (n  1,445)
Age-adjusted Referent 0.55 (0.43–0.70) 0.32 (0.22–0.47) 0.001
Multi-adjusted† Referent 0.57 (0.44–0.73) 0.33 (0.22–0.48) 0.001
Excluding deaths that occurred during
the ﬁrst year of follow-up Referent 0.57 (0.43–0.72) 0.34 (0.23–0.51) 0.001
Data are HRs (95% CI). *P values are for both the moderate-ﬁt and high-ﬁt categories compared with the low-ﬁt category (referent) and for linear trend. †Adjusted
for age, BMI, ACE inhibitors, -blockers, calcium channel blockers, diuretics, statins, hypertension, dyslipidemia, and smoking.
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of Caucasians. In this regard, it is impor-
tant to emphasize that a strong, inverse,
and dose-response reduction in the mor-
tality risk for both African Americans and
Caucasians was observed. Equally impor-
tant is the ﬁnding of racial disparities in
this relationship. More speciﬁcally, we
noted that the exercise-related reduction
in mortality may be stronger and more
graded for Caucasians than for African
Americans. For example, the adjusted
mortality risk reduction per each 1-MET
increase in exercise capacity was signiﬁ-
cantly greater for Caucasians (19%) than
for African Americans (14%). Further-
more, comparisons between ﬁtness cate-
gories revealed signiﬁcant and clinically
relevant differences in the mortality risk
reduction between races. Compared with
those in the low-ﬁt category (5 METs),
the mortality risk reduction for those
achieving 5.1–7.9 METs was 43% for
Caucasians and 34% for African Ameri-
cans. In the high-ﬁt category (8 METs),
the risk was lowered by 67% (an addi-
tional 24% reduction) in Caucasians and
only by 46% (an additional 12% reduc-
tion) in African Americans (Table 3).
It is noteworthy that in our previous
work in 15,600 veterans with multiple
risk factors (1), a close scrutiny of the da-
tabaserevealedthatracialdisparitieswere
evident only in diabetic subjects. The
mechanism(s) responsible for the racial
disparity in the association of exercise ca-
pacity and mortality risk in diabetic men
arenotreadilyevidentandarebeyondthe
scopeofthisstudy.Nevertheless,because
obesity has been identiﬁed as a risk factor
for impaired exercise capacity (21) and is
more common among African Americans
(22), we examined possible racial differ-
ences in the prevalence of obesity as one
likely explanation. However, the preva-
lences of overweight for both African
Americans and Caucasians were 49.8 and
49.0% versus 50.7% for obese, respec-
tively (P  0.35). We also noted no sig-
niﬁcant racial differences in waist
circumference in 182 diabetic subjects
with available waist circumference data
(P  0.116).
Another possible mechanism may be
racial differences in vascular reactivity.
Endothelium-dependentvasodilatationis
signiﬁcantly impaired in healthy African
American adults (23) and diabetic sub-
jects (24) compared with that in the cor-
responding groups of Caucasians. In the
current study, impaired vascular reactiv-
ity may have been more prevalent or
more severe in African Americans than
in Caucasians.
Itisalsopossiblethattheracialdiffer-
ences on the impact of exercise capacity
on mortality risk may be due to racial dif-
ferences on adherence to medical therapy
orsocioeconomicfactorsthatwewerenot
able to account for in this study. We also
probed for racial differences between
thetwositesregardingﬁtnessbutfound
no interactions. Finally, genetic differ-
ences between the two races cannot be
discounted.
Another notable aspect of our study
relates to the socioeconomic strata of our
cohort. Most information on the associa-
tion between exercise capacity and total
mortalityindiabeticsubjectshasbeende-
rived from predominantly middle to up-
per socioeconomic status Caucasians
(3–5). Socioeconomic factors for such in-
dividuals may be more favorable and al-
low for a more optimal management of
theirdiabetes.Thus,thereportedbeneﬁts
of exercise in such populations may be
exaggerated compared with that in indi-
viduals in relatively low socioeconomic
strata. Our cohort consists of Caucasian
and African American veterans who
mostly represent relatively lower socio-
economic strata. Thus, our ﬁndings sup-
port the notion that higher exercise
capacityisassociatedwithlowerall-cause
mortality in men with type 2 diabetes, in-
dependent of socioeconomic status.
Finally, the equal access to high-
quality health care provided by the Veter-
ans Health Administration in the U.S.
Department of Veterans Affairs Health
Care System, independent of a patient’s
ﬁnancial status, strengthens the conten-
tion that increased exercise capacity pro-
vides protection against premature
mortality in diabetic men.
Our study has some limitations. The
inverse association between cardiorespi-
ratory ﬁtness and mortality does not
prove cause and effect relationships. Al-
though similar reciprocal relationships
have been demonstrated between ﬁtness
andCVDmortality,weonlyhadinforma-
tion on all-cause mortality and did not
have data on cardiovascular mortality.
However, using all-cause mortality as an
end point in clinical investigations is
viewed as objective, unbiased, and accu-
rate, whereas use of cardiovascular mor-
tality has been criticized as highly
inaccurate(25).Theonsetofdiabetesand
other chronic diseases, severity and dura-
tion of therapy, and status of physical ac-
tivity could not be evaluated because of
incomplete records. This problem may
explain part of the racial disparity noted.
Finally, our ﬁndings are based on men
only and cannot be extrapolated to
women.
Insummary,ourﬁndingssupportthe
concept that exercise capacity is a strong
predictor of all-cause mortality in African
American and Caucasian men with type 2
diabetes. The reduction is graded and
more pronounced in Caucasians than in
African Americans. It is important to em-
phasize that the inherent limitations of
any epidemiological study do not permit
deﬁnitive statements and that the ﬁnding
regarding racial differences should be
conﬁrmed by future studies. Despite
these limitations, our ﬁndings raise the
intriguing possibility that racial differ-
ences in ﬁtness-related health beneﬁts
may exist and that research on racial dis-
parities should be pursued.
Ourﬁndingsextendthepublichealth
message regarding the health beneﬁts of
cardiorespiratory ﬁtness to men with dia-
betes and support the concept that exer-
cise capacity should be given as much
attention by clinicians as other major risk
factors and that health care professionals
should encourage diabetic subjects to ini-
tiate and maintain a physically active life-
style consisting of moderate-intensity
activities.
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